Table 1 (abstract P1022). See text for description

1

28

started at 12^th Gestational Week (GW) and used until birth

normal

Birth at 40^th GW

girl

vaginal

10

34 mo

No

2

31

Conceived on Anakinra (have been on Anakinra since 2012), discontinued at 29^th GW, reintroduced at 33^th GW due to symptom flare.

normal

Birth at 38^th GW

boy

C/S

6

48 mo

Methicillin-Sensitive Staphylococcus Aureus incision-site infection (treated with Tygecycline) in mother

3

24

started at 15^th GW and useduntil birth

normal

Birth at 38^th GW

boy

Vaginal

8

48 mo

thrombocyte count of the baby was low (23,000/mm³) (After three courses of IVIG, it was increased to 95,000/mm³ and a month later to 269,000/mm³)

4

32

started at 16^th GW, continued for 6 months following the birth at 31^th GW

normal

Birth at 31^th GW

2 girls

C/S

8 for both babies

42 mo

No

5

25

Started at 23^th GW used until birth at 37^th GW

normal

Birth at 37^th GW

girl

C/S

7

42 mo

Injection site reaction

6

29

Started at 32^nd GW, used until birth 40 th GW

normal

Birth at 40^th GW

Girl

C/S

?

37 mo

No

7

33

Started at 2013, conceived under Anakinra. Anakinra was stopped at the first month of pregnancy, she flared and it was reintroduced.

Normal

Birth at 38^th GW

Girl

C/S

8

42 mo

No

8

30

Started at 34th GW, used until still birth at 37^th GW

Intrauterine death at 37^th GW

Pregnancy terminated at 37^th GW

Boy

Normal

0

10 mo

No

9

Zeynep

Started at 6^th GW, still using after birth

Normal

Birth at 36th GW

Girl

C/S

9

9 mo

No